Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
SERB Pharmaceuticals’ Partnership with SFJ Pharmaceuticals
Sonoco’s Acquisition of WestRock’s Remaining Interest in Joint Venture
Freshfields represented Sonoco Products Company. WestRock Company [NYSE: WRK], a leading provider of sustainable paper and packaging solutions, today announced it has entered into a definitive...
Sun King’s $260 Million Series D Funding Round
Freshfields advised BeyondNetZero on the deal. BeyondNetZero acted as lead investor in the $260m Series D funding round of Sun King (formerly Greenlight Planet), the largest...